期刊
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
卷 70, 期 2, 页码 246-252出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.diagmicrobio.2010.12.023
关键词
Acinetobacter; Synergy; Colistin; Doripenem; Transplant
资金
- University of Pittsburgh School of Pharmacy
- University of Pittsburgh, Department of Medicine
Extensively drug-resistant (XDR) Acinetobacter baumannii infections caused 91% (10/11) mortality in transplant recipients. Isolates were colistin-susceptible initially, but susceptibility decreased during therapy in 40% (4/10). We tested antibiotic combinations against XDR Acinetobacter in vitro and demonstrated positive interactions for carbapenem colistin. Subsequently, 80% (4/5) of transplant patients were treated successfully with carbepenem-colistin regimens. Published by Elsevier Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据